Telomir Pharmaceuticals Inc's latest research shows that the company has achieved extensive tumor cell death rates in human triple-negative breast cancer experimental models.
Show original
This groundbreaking development brings new hope for the treatment of this aggressive subtype of breast cancer.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$71,422.24
+6.78%
Ethereum
ETH
$2,072.04
+5.83%
Tether USDt
USDT
$1
+0.01%
BNB
BNB
$652.01
+4.28%
XRP
XRP
$1.41
+4.60%
USDC
USDC
$1.0000
+0.00%
Solana
SOL
$90.5
+7.72%
TRON
TRX
$0.2841
+1.11%
Dogecoin
DOGE
$0.09301
+3.64%
Cardano
ADA
$0.2707
+2.56%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now